$康希诺生物—B(06185)$阿康在俄罗斯注册在即!!7月,俄罗斯工贸部负责人丹尼斯·曼图罗夫表示,Petrovax已准备好生产CanSino疫苗——卫生部颁发了临床试验许可证。他指出,如果测试成功,那么该部门将决定批准该药物在俄罗斯使用。In July, the head of the Russian Ministry of Industry and Trade Denis Manturov said that Petrovax was ready to produce CanSino vaccines - the Ministry of Health issued a permit for clinical trials.He noted that if the tests are successful, then the department will decide on the approval of the drug for use in Russia.原文地址:https://www.tellerreport.com/news/2021-08-02-petrovax-told-about-the-research-of-the-chinese-vaccine-%22convidetsiya%22.SJxH_78Byt.html
$康希诺生物-B(06185)$巴基斯坦康希诺三期的数据预计在2月中旬出来,目前巴基斯坦已经将数据寄往加拿大进行分析。消息来源:https://www.gwadarpro.pk/1354304810439372801/pakistanis-pin-their-hopes-on-cansino-biologics-vaccine原文:Pakistan’s National Command and Operation Center (NCOC) announced the launch of phase-III clinical trials in the country for CanSino Vaccine in end-September 2020. Five different hospitals across the country, with the National Institute of Health (NIH) as principal investigator, initiated the trials with a sample size of 18,000.Talking to China Economic Net (CEN), Dr. Ghazala Parveen, Chief of Biological Production Division NIH said, “So far, we have vaccinated 17,500 volunteers during a double-blind placebo control trial where 50% of people got the vaccine and 50 % got a placebo”. Pla